Study of Blood and Tumor Samples From Men With an Inherited Risk of Prostate Cancer
NCT ID: NCT00959023
Last Updated: 2013-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
21000 participants
OBSERVATIONAL
1993-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PURPOSE: This clinical trial is studying blood and tumor samples from men with an inherited risk of prostate cancer.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* To find genes that predispose to prostate cancer (using genetic linkage and other molecular biology techniques).
* To determine if genes that predispose to prostate cancer are associated with disease and treatment parameters.
* To determine if genes that predispose to prostate cancer are associated with environmental factors.
* To estimate the percentage of prostate cancer patients who have a positive family history of the disease.
* To estimate the relative risk of developing prostate cancer in a currently unaffected member of a prostate cancer family.
* To ascertain whether relatives of prostate cancer patients are at increased risk of developing cancers other than prostate cancer.
* To build up a large blood and tumor (both fresh and preserved) bank from patients with prostate cancer to identify prostate cancer predisposition gene(s), determine the prevalence and penetrance of prostate cancer predisposition genes in prostate cancer patients, correlate changes in prostate cancer predisposition gene(s) with disease and treatment parameters by matching with clinical data from clinical databases already held as part of the medical record on these patients, and correlate changes in prostate cancer predisposition gene(s) with environmental factors collected by questionnaire from these patients.
* To use the blood and tumor bank for marker studies (DNA, RNA, serum, plasma, protein, and other molecules) to define the role of these markers in disease prediction and progression.
* To develop microarrays from prostate cancers to determine their genetic profile and correlate this with prostate cancer genetic predisposition genes.
* To collect tissue from other unaffected and affected members of the family in cases where a genetic alteration is found, in order to ascertain whether this alteration is associated with disease risk.
* To collect tissue samples from unaffected family members who show an interest in taking part in the study.
OUTLINE: Patients are assessed by a family history and epidemiology questionnaire and undergo a medical record review.
Patients and relatives with prostate cancer may undergo blood sample collection for genetic analysis of prostate cancer predisposition genes and measurement of markers of associations with genetic changes associated with prostate cancer. Blood and tumor samples are stored for future studies.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
laboratory biomarker analysis
medical chart review
questionnaire administration
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Meets 1 of the following criteria:
* Diagnosis of prostate cancer meeting any of the following criteria:
* Attending prostate clinics at The Royal Marsden NHS Foundation Trust
* Any age at diagnosis
* Not attending prostate clinics at The Royal Marsden NHS Foundation Trust, meeting 1 of the following criteria:
* No older than 60 years at diagnosis
* Diagnosis in two relatives where one is ≤ 65 years at diagnosis
* At any age in a cluster with 3 or more cases
* Any unaffected male relatives of men who are already taking part in the study
PATIENT CHARACTERISTICS:
* Able to understand the information sheet and give informed consent
* No man who is too ill to take part
PRIOR CONCURRENT THERAPY:
* Not specified
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institute of Cancer Research, United Kingdom
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rosalind Eeles, PhD, FRCR, FRCP, FMed Sci
Role: PRINCIPAL_INVESTIGATOR
Royal Marsden NHS Foundation Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
William Harvey Hospital
Ashford-Kent, England, United Kingdom
Tameside General Hospital
Ashton-under-Lyne, England, United Kingdom
Stoke Mandeville Hospital
Aylesbury-Buckinghamshire, England, United Kingdom
North Devon District Hospital
Barnstaple, England, United Kingdom
Furness General Hospital
Barrow in Furness, England, United Kingdom
Basildon University Hospital
Basildon, England, United Kingdom
Basingstoke and North Hampshire NHS Foundation Trust
Basingstoke, England, United Kingdom
Royal United Hospital
Bath, England, United Kingdom
Primrose Centre at Bedford Hospitals NHS Trust
Bedford, England, United Kingdom
Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust
Birmingham, England, United Kingdom
City Hospital - Birmingham
Birmingham, England, United Kingdom
Good Hope Hospital
Birmingham, England, United Kingdom
Birmingham Heartlands Hospital
Birmingham, England, United Kingdom
Royal Blackburn Hospital
Blackburn, England, United Kingdom
Blackpool Victoria Hospital
Blackpool, England, United Kingdom
Pilgrim Hospital
Boston, England, United Kingdom
Royal Bournemouth Hospital
Bournemouth, England, United Kingdom
Sussex Cancer Centre at Royal Sussex County Hospital
Brighton, England, United Kingdom
Southmead Hospital
Bristol, England, United Kingdom
Frenchay Hospital
Bristol, England, United Kingdom
Bristol Royal Infirmary
Bristol, England, United Kingdom
Broomfield Hospital
Broomfield, England, United Kingdom
Burnley General Hospital
Burnley, England, United Kingdom
Queen's Hospital
Burton-on-Trent, England, United Kingdom
Addenbrooke's Hospital
Cambridge, England, United Kingdom
Kent and Canterbury Hospital
Canterbury, England, United Kingdom
St. Helier Hospital
Carshalton, England, United Kingdom
Countess of Chester Hospital
Chester, England, United Kingdom
Colchester General Hospital
Colchester, England, United Kingdom
Castle Hill Hospital
Cottingham, England, United Kingdom
Walsgrave Hospital
Coventry, England, United Kingdom
Mid Cheshire Hospitals Trust- Leighton Hopsital
Crewe, England, United Kingdom
Mayday University Hospital
Croydon, England, United Kingdom
Darent Valley Hospital
Dartford Kent, England, United Kingdom
Derbyshire Royal Infirmary
Derby, England, United Kingdom
Royal Derby Hospital
Derby, England, United Kingdom
Dorset County Hospital
Dorchester, England, United Kingdom
Russells Hall Hospital
Dudley, England, United Kingdom
Eastbourne District General Hospital
Eastbourne, England, United Kingdom
Birmingham Women's Hospital
Edgbaston, England, United Kingdom
Epsom General Hospital
Epsom, Surrey, England, United Kingdom
Royal Devon and Exeter Hospital
Exeter, England, United Kingdom
Royal Bolton Hospital
Farnworth, England, United Kingdom
Frimley Park Hospital
Frimley, England, United Kingdom
Grantham and District Hospital
Grantham, Lincolnshire, England, United Kingdom
Diana Princess of Wales Hospital
Grimsby, England, United Kingdom
Harrogate District Hospital
Harrogate, England, United Kingdom
Wycombe General Hospital
High Wycombe, England, United Kingdom
Princess Royal Hospital at Hull and East Yorkshire NHS Trust
Hull, England, United Kingdom
Ipswich Hospital
Ipswich, England, United Kingdom
Kidderminster Hospital
Kidderminster Worcestershire, England, United Kingdom
Royal Albert Edward Infirmary
Lancanshire, England, United Kingdom
Royal Lancaster Infirmary
Lancaster, England, United Kingdom
Leeds General Infirmary
Leeds, England, United Kingdom
Cookridge Hospital
Leeds, England, United Kingdom
Leeds Cancer Centre at St. James's University Hospital
Leeds, England, United Kingdom
Leicester Royal Infirmary
Leicester, England, United Kingdom
Leicester General Hospital
Leicester, England, United Kingdom
Lincoln County Hospital
Lincoln, England, United Kingdom
Royal Liverpool University Hospital
Liverpool, England, United Kingdom
Royal London Hospital
London, England, United Kingdom
Whipps Cross Hospital
London, England, United Kingdom
Saint Bartholomew's Hospital
London, England, United Kingdom
Guy's Hospital
London, England, United Kingdom
Hammersmith Hospital
London, England, United Kingdom
Middlesex Hospital
London, England, United Kingdom
St. Mary's Hospital
London, England, United Kingdom
Charing Cross Hospital
London, England, United Kingdom
Macclesfield District General Hospital
Macclesfield, England, United Kingdom
Maidstone Hospital
Maidstone, England, United Kingdom
Christie Hospital
Manchester, England, United Kingdom
Clatterbridge Centre for Oncology
Merseyside, England, United Kingdom
James Cook University Hospital
Middlesbrough, England, United Kingdom
Milton Keynes General Hospital
Milton Keynes, England, United Kingdom
Newcastle Upon Tyne Hospitals NHS Trust
Newcastle upon Tyne, England, United Kingdom
Mount Vernon Cancer Centre at Mount Vernon Hospital
Northwood, England, United Kingdom
Norfolk and Norwich University Hospital
Norwich, England, United Kingdom
Nottingham City Hospital
Nottingham, England, United Kingdom
Kings Mill Hospital
Nottinghamshire, England, United Kingdom
George Eliot Hospital
Nuneaton, England, United Kingdom
Churchill Hospital
Oxford, England, United Kingdom
Peterborough Hospitals Trust
Peterborough, England, United Kingdom
Derriford Hospital
Plymouth, England, United Kingdom
Dorset Cancer Centre
Poole Dorset, England, United Kingdom
Rosemere Cancer Centre at Royal Preston Hospital
Preston, England, United Kingdom
Berkshire Cancer Centre at Royal Berkshire Hospital
Reading, England, United Kingdom
Alexandra Healthcare NHS
Redditch, Worcestershire, England, United Kingdom
Queens Hospital
Romford, England, United Kingdom
Conquest Hospital
Saint Leonards-on-Sea, England, United Kingdom
Hope Hospital
Salford, England, United Kingdom
Salisbury District Hospital
Salisbury, England, United Kingdom
Scarborough General Hospital
Scarborough, England, United Kingdom
Scunthorpe General Hospital
Scunthorpe, England, United Kingdom
Royal Shrewsbury Hospital
Shrewsbury, England, United Kingdom
Wexham Park Hospital
Slough, Berkshire, England, United Kingdom
Solihull Hospital
Solihull, England, United Kingdom
Southampton General Hospital
Southampton, England, United Kingdom
Southport and Formby District General Hospital
Southport, England, United Kingdom
Staffordshire General Hospital
Stafford, England, United Kingdom
Lister Hospital
Stevenage, England, United Kingdom
Stirling Royal Infirmary
Stirling, England, United Kingdom
Stepping Hill Hospital
Stockport, England, United Kingdom
Kingston Hospital
Surrey, England, United Kingdom
East Surrey Hospital
Surrey, England, United Kingdom
Royal Marsden - Surrey
Sutton, England, United Kingdom
Great Western Hospital
Swindon, England, United Kingdom
Taunton and Somerset Hospital
Taunton, England, United Kingdom
Torbay Hospital
Torquay, England, United Kingdom
Hillingdon Hospital
Uxbridge, England, United Kingdom
Warwick Hospital
Warwick, England, United Kingdom
Sandwell General Hospital
West Bromwich, England, United Kingdom
Southend University Hospital NHS Foundation Trust
Westcliff-on-Sea, England, United Kingdom
New Cross Hospital
Wolverhampton, England, United Kingdom
Worthing Hospital
Worthing, England, United Kingdom
Yeovil District Hospital
Yeovil, England, United Kingdom
Cancer Care Centre at York Hospital
York, England, United Kingdom
Belfast City Hospital Trust Incorporating Belvoir Park Hospital
Belfast, Northern Ireland, United Kingdom
Downe Hospital
Downpatrick, Northern Ireland, United Kingdom
Altnagelvin Area Hospital
Londonderry, Northern Ireland, United Kingdom
Craigavon Area Hospital
Portadown, Craigavon, Northern Ireland, United Kingdom
Aberdeen Royal Infirmary
Aberdeen, Scotland, United Kingdom
Ayr Hospital
Ayr, Scotland, United Kingdom
Falkirk and District Royal Infirmary
Falkirk, Scotland, United Kingdom
Western Infirmary
Glasgow, Scotland, United Kingdom
Pinderfields General Hospital
Wakefield, Scotland, United Kingdom
Princess of Wales Hospital
Bridgend, Wales, United Kingdom
Velindre Cancer Center at Velindre Hospital
Cardiff, Wales, United Kingdom
University Hospital of Wales
Cardiff, Wales, United Kingdom
Royal Gwent Hospital
Newport Gwent, Wales, United Kingdom
Glan Clwyd Hospital
Rhyl, Denbighshire, Wales, United Kingdom
Singleton Hospital
Swansea, Wales, United Kingdom
Queen Victoria Hospital
Morecambe, , United Kingdom
Edith Cavell Hospital
Peterborough, , United Kingdom
Southlands Hospital
Shoreham-by-Sea, , United Kingdom
Princess Anne Hospital
Southampton, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Contact Person
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ICR-UKGPCS
Identifier Type: -
Identifier Source: secondary_id
EU-20909
Identifier Type: -
Identifier Source: secondary_id
CDR0000636371
Identifier Type: -
Identifier Source: org_study_id